home.aspx
 
EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

CODAC Behavioral Health Services, Inc.

CODAC is one of Arizona’s oldest and most respected community providers of specialty care for mental illness, addiction and trauma. What began as a grassroots drug abuse prevention program has grown into a multi-faceted organization that provides services across the entire spectrum of behavioral health care. Through 11 service locations and over 400 staff and volunteers, CODAC now serves more than 15,000 individuals and families each year. CODAC is a nonprofit 501(C)(3) organization. We are here to help you meet your mental health, substance abuse, trauma, primary care and general wellness goals. A variety of treatment professionals will partner with you to develop a plan and take positive steps toward a healthy, productive, caring life in recovery from a mental illness, substance use disorder and/or trauma.

RELATED NEWS


Prime minister Theresa May has pledged an extra £3.5 billion per year annual funding for NHS primary and community healthcare in England. The spending is part of the NHS long-term plan, backed by £20.5 billion over the next five years, and is intended to improve care in the home and release pressure on overcrowded hospitals. Funding will go toward 24/7 community-based rapid response teams, consisting of doctors, nurses, and physiotherapists who will provide urgent care for patients a...

READ MORE

Amgen and UCB’s application to market bone-boosting drug Evenity as a treatment for postmenopausal women with osteoporosis has hit a setback, having been turned down by US regulators. The US Food and Drug Administration has issued a Complete Response Letter asking for new safety and efficacy data from the Phase III active-comparator ARCH study to be integrated into the drug’s submission, to build on that included in the original filing taken from the Phase III placebo-controlled FRAME study. The...

READ MORE

Roche’s Flatiron Health and the U.S. Food and Drug Administration (FDA)’s Information Exchange and Data Transformation (INFORMED) Program expanded a two-year-old collaboration agreement. The agreement, forged in 2016, has enabled the regulatory agency to gain a better understanding of how real-world-evidence derived from de-identified patient datasets curated from electronic health records, can support regulatory decision-making. Since the agreement was first struck, the FDA and Flat...

READ MORE

Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their research and what their future might look like....

READ MORE

Ten years later, the pharmaceutical industry in Michigan has more than rebounded from Pfizer Corp.'s shutdown of its Ann Arbor and Kalamazoo research operations....

READ MORE

If the first few years of the Cannes Lions Health served to inspire pharma advertising creativity, this year was the payoff. With double-digit pharma wins for the first time in the festival's history, the industry validated its claim on the Cannes call for life-changing creativity. The pharma company winners and finalist contenders were a who's who in the industry. The big scorers that picked up Lions were Boehringer Ingelheim, Bayer, Takea, Eli Lilly, Biogen and Novartis in the U.S., wh...
FIERCEPHARMA
READ MORE

EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...